Hasil Pencarian
Ditemukan 610 dokumen dengan kata kunci 7597 Simpan CSV Simpan CSV
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.1999-2004 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients
No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.655-661 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA
No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2278-2284 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy
No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.2068-2073 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1841-1847 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer
No. Panggil: Annals of Oncology; Volume 24, No.9, September, 2013, p.2316-2324 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
No. Panggil: Annals of Oncology; Volume 24, No.3, Maret, 2013, p.632-639 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
No. Panggil: Annals of Oncology; Volume 24, No.6, June, 2013, p.1498-1505 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer?†
No. Panggil: Annals of Oncology; Volume 24, No.7, Juli, 2013, p.1834-1840 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer
No. Panggil: Annals of Oncology; Volume 24, No.8, August, 2013,p.2005-20011 |
Koleksi: Artikel Internasional - Oxford  :: Cari yang mirip  :: Tambahkan ke Favorit  ::
Prev   1 2 3 4 5 6 7 8 9 10  Next